Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 94 (1), 13-20
- https://doi.org/10.1016/0002-9343(93)90114-5
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Plasma triglyceride and coronary heart disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisPublished by American Medical Association (AMA) ,1990
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.Circulation, 1990
- Role of fibric acids in the management of hyperlipidemiaCurrent Opinion in Lipidology, 1990
- The HMG CoA reductase inhibitorsCurrent Opinion in Lipidology, 1990
- The cholesterol controversy is over. Why did it take so long?Circulation, 1989
- The Place of HDL in Cholesterol ManagementArchives of Internal Medicine, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984